A Multicenter, Prospective, Randomized, Placebo-Controlled, Double-Blind Study of a Novel Pain Management Device, AT-02, in Patients with Fibromyalgia. med. app.

Published in: Pain Med 2020; 21 (2): 326-332

Exposure